홈 / 종목 / TEVA PHARMACEUTICAL INDS LTD
TEVA PHARMACEUTICAL INDS LTD
2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
보유 슈퍼인베스터
| 슈퍼인베스터 | 보유수량 | 평가액 | 비중 | 구분 |
|---|---|---|---|---|
| 버크셔 해서웨이 | 43,249,295 | $297.6M | 0.1% | - |
| 애브람스 캐피털 매니지먼트 | 24,046,356 | $165.4M | 4.6% | 추가 |
| 밀러 밸류 파트너스 | 8,491,152 | $58.42M | 2.4% | 추가 |
| 매버릭 캐피털 | 661,215 | $4.549M | 0.1% | 신규 |
| 셔우 어소시에이츠 | 15,000 | $103K | 0.1% | - |
분기별
| 분기 | 보유 슈퍼인베스터 | 합계 금액 |
|---|---|---|
| 2013-06-30 | 5 | $151.9M |
| 2013-09-30 | 4 | $49.9M |
| 2013-12-31 | 4 | $52.18M |
| 2014-03-31 | 4 | $65.53M |
| 2014-06-30 | 4 | $64.8M |
| 2014-09-30 | 4 | $129.3M |
| 2014-12-31 | 3 | $171.9M |
| 2015-03-31 | 4 | $310.2M |
| 2015-06-30 | 3 | $253.9M |
| 2015-09-30 | 4 | $782.8M |
| 2015-12-31 | 4 | $1.957B |
| 2016-03-31 | 4 | $1.889B |
| 2016-06-30 | 4 | $1.414B |
| 2016-09-30 | 4 | $925.7M |
| 2016-12-31 | 4 | $201.3M |
| 2017-03-31 | 4 | $80.12M |
| 2017-06-30 | 3 | $20.38M |
| 2017-09-30 | 4 | $389.5M |
| 2017-12-31 | 6 | $741.9M |
| 2018-03-31 | 4 | $1.068B |
| 2018-06-30 | 4 | $1.595B |
| 2018-09-30 | 4 | $1.437B |
| 2018-12-31 | 5 | $1.017B |
| 2019-03-31 | 5 | $1.034B |
| 2019-06-30 | 4 | $625.9M |
| 2019-09-30 | 5 | $526.1M |
| 2019-12-31 | 4 | $760.4M |
| 2020-03-31 | 3 | $671.3M |
| 2020-06-30 | 3 | $920.9M |
| 2020-09-30 | 4 | $676.2M |
| 2020-12-31 | 4 | $714.3M |
| 2021-03-31 | 4 | $894.9M |
| 2021-06-30 | 4 | $770.4M |
| 2021-09-30 | 3 | $745.9M |
| 2021-12-31 | 3 | $276M |
| 2022-03-31 | 3 | $329.6M |
| 2022-06-30 | 3 | $260M |
| 2022-09-30 | 3 | $277M |
| 2022-12-31 | 4 | $200.1M |
| 2023-03-31 | 4 | $111.3M |
| 2023-06-30 | 4 | $63.29M |
| 2023-09-30 | 5 | $163.8M |
| 2023-12-31 | 5 | $157.6M |
| 2024-03-31 | 5 | $112.7M |
| 2024-06-30 | 5 | $118M |
| 2024-09-30 | 6 | $253.2M |
| 2024-12-31 | 6 | $261.6M |
| 2025-03-31 | 4 | $248.6M |
| 2025-06-30 | 4 | $430.5M |
| 2025-09-30 | 4 | $328.4M |
| 2025-12-31 | 2 | $230M |
| 2026-03-31 | 2 | $204.7M |
| 2026-06-30 | 2 | $226.7M |